by Dr. Joseph Mercola
preprint paper showing ivermectin's effectiveness
against COVID-19 in Peru convinced a group of doctors
that widespread ivermectin distribution could end the
'pandemic' in October 2020
Because the paper wasn't yet peer-reviewed, it was
brushed off; ivermectin for COVID-19 was vilified, as
were those who dared to prescribe it
the study has been peer-reviewed and published in Cureus,
vindicating ivermectin as a treatment for COVID-19
only did ivermectin work against COVID-19, it was
remarkably effective, resulting in a 74% reduction in
excess deaths in the 10 Peru states where it was used
There was a 14-fold reduction in nationwide excess
deaths when ivermectin was readily available and then a
13-fold increase in excess deaths in the two months
after ivermectin use was restricted
As the COVID 'pandemic' wore on, with potential treatments supposedly
unknown, New York pulmonologist Dr.
Pierre Kory and others
tried to get the word out
A widely used
antiparasitic drug that's listed on the World Health Organization's
(WHO) essential medicines list 1 and approved by the U.S.
Food and Drug
Administration (FDA), ivermectin is widely available, inexpensive and has
a long history of safe usage.
In fact, since 1987, 3.7 billion doses of ivermectin have been used
among humans worldwide, 2 but it was quickly vilified - as were those
who dared to prescribe it.
Now, the tables have
Not only did ivermectin
work against COVID-19, it was remarkably effective, resulting in a
74% reduction in excess deaths in the 10 states where it was used
most intensively. 3
Dramatically Slashed COVID Deaths
Kory and other physicians with the Front Line COVID-19 Critical Care
Working Group (FLCCC
- But see the
Wikipedia info, website that is
to George Soros) had success early on treating patients with
ivermectin and other therapies during the 'pandemic'.
His efforts to get the
word out on this treatment protocol were stifled by censorship,
ridicule and colleagues brainwashed by the official narrative and
unwilling to accept the science.
A preprint paper showing ivermectin's effectiveness against
"was the final piece
of evidence which convinced me, Paul [Marik] and the FLCCC that
widespread ivermectin distribution could end the 'pandemic' in Oct
of 2020," Kory tweeted. 4
"Took 2 years but now
peer-reviewed & published in a major journal."
study, published in Cureus, 5 vindicates ivermectin as a treatment for COVID-19.
"Reductions in excess
deaths over a period of 30 days after peak deaths averaged 74%
in the 10 states with the most intensive IVM [ivermectin] use,"
the study found. 6
It used Peruvian national
health data from Peru's 25 states to evaluate ivermectin's effects.
A natural experiment was set in motion in May 2020, when Peru
authorized ivermectin for COVID-19. The significant reduction in
excess deaths noted "correlated closely with the extent of IVM use,"
the researchers noted.
Stories Highlight Ivermectin's Potential
Few have heard about the astonishing success of ivermectin in
Uttar Pradesh, India, which embraced large-scale prophylactic and
therapeutic use of ivermectin for COVID-19 patients, close contacts
of patients and health care workers. 7
"The possibility of
both preventative and treatment efficacies of IVM was raised by
outcomes in another world region in which IVM was distributed to
the population at risk for COVID-19 on a mass scale.
This IVM distribution
occurred in Uttar Pradesh, the largest state in India, having a
population of 229 million," the study added. 8
ivermectin distribution likely resulted in significantly lower
COVID-19 deaths compared to areas not using the drug: 9
"The cumulative total
of COVID-19 deaths per million in population from July 7, 2021
through April 1, 2023 was 4.3 in Uttar Pradesh, as compared with
70.4 in all of India and 1,596.3 in the United States...
The much lower number
of COVID-19 deaths per population in all of India versus the
United States in that period may reflect the use of these same
home treatment kits containing IVM, doxycycline, and zinc in
some other states of India."
A similar series of
events occurred in Itajai, Brazil, a city of 220,000 people.
In June 2020, they
implemented a prophylaxis program using ivermectin. The program was
advertised throughout local media, and people were encouraged to
participate and take ivermectin four times a month, on days 1, 2, 15
On the appropriate days, they set up tents and centers where people
could get the drug, and the entire program was carefully logged in
an electronic database.
In all, 159,000 Brazilians participated, of
those 113,000 elected to take the ivermectin.
Kory and eight coauthors published a paper on the results, which
"regular use of
ivermectin as a prophylactic agent was associated with
significantly reduced COVID-19 infection, hospitalization, and
mortality rates." 10
Those who used ivermectin
a 44% reduction in COVID-19 infection rate
a 68% reduction in
a 56% reduction in hospitalization rate,
...compared to those who did not. 11
Meanwhile, a study from Japan demonstrated that just 12 days after
doctors were allowed to legally prescribe ivermectin to their
COVID-19 patients, cases dropped dramatically. 12
The chairman of the Tokyo
Medical Association 13 noticed the low number of infections and
deaths in Africa, where many use ivermectin prophylactically and as
the core strategy to treat river blindness. 14
Ivermectin Restrictions Increased Deaths
In a striking revelation, ivermectin was used against COVID-19 in
Peru for four months, before the new president (Dina
Boluarte) put restrictions on
During that time,
"there was a 14-fold
reduction in nationwide excess deaths and then a 13-fold
increase in the two months following the restriction of IVM
The U.S. Food and Drug
Administration (FDA) has towed the anti-ivermectin narrative all along,
with its infamous tweet reading,
"You are not a horse.
You are not a cow. Seriously, y'all. Stop it." 16
While commanding the U.S.
public and physicians not to use ivermectin for an off-label use,
the irony stands that close to 40% of U.S. prescriptions are for
off-label uses. 17
But now, after years of vilification, it had no choice but to admit
what's been right all along:
doctors have the authority to
prescribe ivermectin for COVID-19.
Attorney Jared Kelson
of Boyden Gray & Associates, who is representing physicians who have
the FDA for interfering with their practice of medicine,
including relating to ivermectin for COVID-19, explained: 18
issue is straightforward.
After the FDA approves a human drug
for sale, does it then have the authority to influence or
interfere with how that drug is used within the doctor-patient
The answer is no."
The FDA did just that,
nonetheless, but finally admitted the truth on August 16, 2023,
professionals generally may choose to prescribe an approved
human drug for an unapproved use when they judge that the
unapproved use is medically appropriate for an individual
In September 2021, the
American Medical Association also told doctors to stop prescribing ivermectin for COVID-19.
In a statement, AMA,
along with the American Pharmacists Association (APhA) and American
Society of Health-System Pharmacists (ASHP), warned: 20
"We are alarmed by
reports that outpatient prescribing for and dispensing of
ivermectin have increased 24-fold since before the 'pandemic' and
increased exponentially over the past few months.
As such, we are
calling for an immediate end to the prescribing, dispensing, and
use of ivermectin for the prevention and treatment of COVID-19
outside of a clinical trial.
In addition, we are urging physicians, pharmacists, and other
prescribers - trusted health care professionals in their
communities - to warn patients against the use of ivermectin
outside of FDA-approved indications and guidance, whether
intended for use in humans or animals, as well as purchasing
ivermectin from online stores."
How many died
unnecessarily as a result of these commands..?
As noted by journalist
Kim Iversen, even the FDA's move advising doctors that they're
allowed to prescribe ivermectin for COVID-19 is too little, too
"Now, two, three
years later, too little, too late... ultimately, we now get this
study that has been officially peer reviewed and published, and
it shows significant, significant, significant reduction [of
mortality] in COVID-19." 21
Ivermectin Work Against COVID?
Ivermectin binds to
SARS-CoV-2's spike protein, limiting the virus'
morbidity and infectivity. 22
The drug, while best
known for its antiparasitic effects, also has demonstrated
and anti-inflammatory properties.
An in vitro study demonstrated
that a single treatment with ivermectin effectively reduced viral
load 5,000 times in 48 hours in cell culture. 23
Studies have shown that ivermectin helps to lower the viral load by
inhibiting replication. 24
A single dose of ivermectin
can kill 99.8% of the virus within 48 hours. 25
A meta-analysis in the
American Journal of Therapeutics also showed the drug reduced
infection by an average of 86% when used preventively. 26
Ivermectin has also been shown to speed recovery, in part by
inhibiting inflammation and protecting against organ damage.
pathway also lowers the risk of hospitalization and death.
Meta analyses have shown
an average reduction in mortality that ranges from 75% 28
to 83%. 29,30
Additionally, the drug also prevents transmission of SARS-CoV-2 when
taken before or after exposure. 31
As the Cureus study
noted, the latest data only adds further evidence that ivermectin
has an important place in COVID-19 treatment: 32
results from IVM treatments in Peru and similar positive
indications from Uttar Pradesh, India, which have populations of
33 million and 229 million, respectively, offer promising models
for further mass deployments of IVM, as needs may arise, for
both the treatment and prevention of COVID-19."
It's worth noting, too,
that ivermectin has notable antitumor effects, which include,
inhibiting proliferation, metastasis and angiogenic activity in
cancer cells. 33
It appears to inhibit
tumor cells by regulating multiple signaling pathways, which
researchers explained in the Pharmacological Research journal,
ivermectin may be an anticancer drug with great potential."
Why Was Ivermectin Suppressed?
Interview Transcript -
The average treatment cost for ivermectin is $58. 35
Do you think this has
anything to do with ivermectin's vilification...?
The authors of the Cureus
study certainly do: 36
safety profile and low cost of IVM (ivermectin) certainly support its use as
in Peru's operation MOT [Mega-Operación Tayta] and in Uttar
Pradesh as an attractive national policy for COVID-19
reductions in mortality as achieved in Peru and Uttar Pradesh
suggest that the impact of such a national IVM deployment would
be observable within a relatively short period.
However, generic drugs have often fared poorly in competition
with patented offerings in past decades, based upon the
unfortunate vulnerability of science to commodification and
Such a potential bias
against IVM was suggested by a February 4, 2021 press release
from Merck, which was then developing its own patented COVID-19
therapeutic, claiming that there was 'a concerning lack of
safety data' for IVM.
However, IVM is Merck's own drug, found safe at doses
considerably higher than its standard dose in several studies,
as cited in the section on the background on IVM treatments of
COVID-19, and the Nobel Prize committee specifically noted IVM's
safety record in honoring the discovery of this drug in its 2015
prize for medicine."
If you'd like to learn
more about ivermectin's potential uses for COVID-19, FLCCC's I-CARE
protocol can be downloaded in full, 37 giving you step-by-step
instructions on how to prevent and treat the early symptoms of
March 31, 2021
2, 5, 6, 8, 9, 15, 22, 32, 36 Cureus
August 8, 2023
August 19, 2023
The Vigilant Fox August 15, 2023
Express May 12, 2021
10, 11 Cureus.
2022 Jan; 14(1): e21272
November 23, 2021 Min 1:25
Web, August 13, 2021
Health Organization, Onchocerciasis
Broken Truth August 13, 2023
17, 18 Courthouse
News Service August 8, 2023
U.S. FDA August 16, 2023
September 1, 2021
FLCCC August 15, 2023
24, 31 FLCCC
Summary of Clinical Trials Evidence for Ivermectin in
April 6, 2020
Journal of Therapeutics, 2021;28(4) Therapeutic Advances
Line COVID-19 Critical Care Alliance, August 29, 2021
January 7, 2021 Press Release (PDF)
Policy Research December 31, 2020
Medicine Consultancy Ltd. Rapid Review and Meta-Analysis
January 3, 2021 (PDF)
33, 34 Pharmacol
Res. 2021 Jan; 163: 105207